跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vicks VapoDrops Xtra Strong Menthol Blast Centres lozenges - TGA Drug Approval Details
Approvals
/
TGA
/
Vicks VapoDrops Xtra Strong Menthol Blast Centres lozenges
Approved
STANDARD
Vicks VapoDrops Xtra Strong Menthol Blast Centres lozenges
Procter & Gamble Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fbf55550b7e2fa57
Company
Procter & Gamble Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
fbf55550b7e2fa57
Product Name
Vicks VapoDrops Xtra Strong Menthol Blast Centres lozenges
Artg Id
373325
Artg Name
Vicks VapoDrops Xtra Strong Menthol Blast Centres lozenges
Sponsor
Procter & Gamble Australia Pty Ltd
Company Detail Path
/organization/procter-and-gamble-australia-pty-limited
Artg Date
2021-08-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fbf55550b7e2fa57
Type
Standard
Back to TGA Approvals
